PubMed=25241739; DOI=10.1016/j.stemcr.2014.07.006
Rasmussen M.A., Holst B., Tumer Z., Johnsen M.G., Zhou S.-L., Stummann T.C., Hyttel P., Clausen C.
Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage.
Stem Cell Reports 3:404-413(2014)

PubMed=27596958; DOI=10.1016/j.scr.2016.07.004
Hansen S.K., Stummann T.C., Borland H., Hasholt L.F., Tumer Z., Nielsen J.E., Rasmussen M.A., Nielsen T.T., Daechsel J.C.A., Fog K., Hyttel P.
Induced pluripotent stem cell-derived neurons for the study of spinocerebellar ataxia type 3.
Stem Cell Res. 17:306-317(2016)

PubMed=30660866; DOI=10.1016/j.scr.2018.11.010
Schmid B., Prehn K.R., Nimsanor N., Aldana Garcia B.I., Poulsen U., Jorring I., Rasmussen M.A., Clausen C., Mau-Holzmann U.A., Ramakrishna S., Muddashetty R.S., Steeg R., Bruce K., Mackintosh P., Ebneth A., Holst B., Cabrera-Socorro A.
Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line.
Stem Cell Res. 34:101349-101349(2019)

PubMed=33660062; DOI=10.1007/s00204-021-03018-y
Lauschke K., Treschow A.F., Rasmussen M.A., Davidsen N., Holst B., Emneus J., Taxvig C., Vinggaard A.M.
Creating a human-induced pluripotent stem cell-based NKX2.5 reporter gene assay for developmental toxicity testing.
Arch. Toxicol. 95:1659-1670(2021)